Bionic pancreas could help people with type 1 diabetes

Researchers are hopeful that an artificial pancreas they have developed will make life easier for people with type 1 diabetes.
The device is an automated pump that releases the hormones insulin and glucagon, and works with a glucose monitoring system that is controlled by an iPhone app, The Boston Globe reports. Researchers from Massachusetts General Hospital and Boston University studied 52 adults and children who used the artificial pancreas and were allowed to eat whatever they wanted. "They went on a diabetes vacation, eating ice cream, candy bars, and other things they normally wouldn't eat," says Dr. Steven Russell, an endocrinologist at Massachusetts General Hospital.
All participants were closely monitored, and the researchers found that the adult patients with type 1 diabetes who used the device had lower blood sugar levels than the control group, while the children did not experience a significant difference in the blood sugar measurements. The adults also spent 67 percent less time in a state of hypoglycemia, and the children experienced a 50 percent reduction in carbohydrate use to treat hypoglycemia.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The device still needs to undergo more testing, but it could be available as early as 2017. "The initial proof of concept is very strong," said Dr. Guillermo Arreaza-Rubin, a director of the National Institute of Diabetes and Digestive and Kidney Diseases, which funded the study. "Parents of children with type 1 live in permanent fear, and maybe this device can free them from that burden and increase the quality of life of those with this disease."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Today's political cartoons - March 8, 2025
Cartoons Saturday's cartoons - trade wars, healthcare costs, and more
By The Week US Published
-
Marbled tea eggs recipe
The Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
By The Week UK Published
-
The Washington Post: kowtowing to Trump?
Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published